Bloodwork question about hexarelin. Baseline, three weeks in, and the numbers moved in a direction I did not expect.
Two weeks is not enough time to attribute anything to a compound unless the effect is dramatic.
What the growth hormone secretagogue class does pharmacologically does not require the subjective effect to be large to be real.
I would rather have a narrow conclusion and be right than a broad one and be interesting.
Timing around sleep matters more than absolute dose with this class.
The interesting question is not whether it works but for whom and at what cost.
How long before you can reasonably say something is or is not doing anything?
Loose evidence and no evidence are different, and people overcorrect in both directions.
Baseline first. Not on hexarelin but the pattern is familiar.
Baseline first.
Stupid question: how do you know whether what is in the vial matches the label at all? Same for me with hexarelin, unfortunately.
Baseline first.
Stupid question: how do you know whether what is in the vial matches the label at all? Same for me with hexarelin, unfortunately.
Baseline first.
An inconclusive account is useful if it stops the next person mistaking a story for a controlled comparison.
An inconclusive account is useful if it stops the next person mistaking a story for a controlled comparison.
Test one thing at a time. It feels slower and it is the only way to learn anything.
Log dose, time and sleep. Ten seconds a day and it turns the anecdote into something you can look at.
An inconclusive account is useful if it stops the next person mistaking a story for a controlled comparison. Three weeks in on hexarelin and it lines up.
Where does the human data stop and the extrapolation begin? That is the whole thread.